New nerve block aims to cut opioid use after hysterectomy

NCT ID NCT07483190

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a special nerve block called M-TAPA can reduce pain and the need for strong painkillers after laparoscopic hysterectomy. Sixty women having the surgery will be randomly assigned to receive either the nerve block or standard care. Researchers will measure how much morphine they use and their pain scores in the first 24 hours.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

bupivacaine

What this could lead to

If it works, this nerve block could become a standard way to reduce pain and opioid use after hysterectomy, leading to faster recovery.

What could go wrong

This is a small, early-stage trial (60 people) testing a specific procedure. Results may not apply to all patients or surgeries, and the block may not reduce pain significantly.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Istinye University Liv Hospital Bahcesehir

    RECRUITING

    Istanbul, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••